Teva Pharmaceutical Industries Files 2014 Annual Report On Form 20-F

In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (“Teva”) announced today that it has filed its 2014 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission.

Help employers find you! Check out all the jobs and post your resume.

Back to news